"They might increase lifespan by a little bit or they might increase it by a lot,” says Tahlia Fulton at the University of Sydney in Australia. Introduction The quest to extend healthy human lifespan has long captivated biomedical science, yet few interventions have generated as much rigorous scientific interest as rapamycin. First described in the 1970s as…

Navigating the landscape of geroprotectors requires a shift from traditional disease treatment to proactive biological optimization. Rapamycin dosing for longevity has moved beyond theoretical mouse models and into the clinics of specialty practitioners, yet the transition from a daily transplant drug to an intermittent anti-aging protocol requires precision to maximize autophagy while avoiding metabolic pitfalls.…

A medication once reserved for preventing organ rejection, rapamycin is now gaining momentum in the field of longevity and rapamycin for anti-aging research. Initially created as an immunosuppressive drug, rapamycin is now being studied for its potential to slow aging and support rapamycin lifespan extension in humans. With growing scientific support pointing to its possible…